Notice to the Public

All times are approximate and subject to change. The meeting may be cancelled without notice. A lunch break will be taken at a time determined by the committee members. Agenda items may be taken out of order to accommodate speakers and to maintain a quorum. Action may be taken on any item on the agenda. This committee meeting is open to the public and is accessible to the physically disabled. A person who needs a disability-related accommodation or modification in order to participate in the meeting may make a request by contacting Kaila Fayne at Kaila.Fayne@dca.ca.gov or (916) 465-9120. Providing your request at least five business days before the meeting will help to ensure availability of the requested accommodation.

The Bureau plans to webcast this meeting online. Webcast availability cannot, however, be guaranteed due to limitations on resources or technical difficulties that may arise. To view the meeting webcast, please visit the following link: https://thedcapage.blog/webcasts/.

If you wish to participate, please plan to attend at the physical location. Seating for all attendees cannot, however, be guaranteed in the event the room reaches capacity.

Interested parties should access the Bureau’s website for more information at http://bcc.ca.gov/. Requests for further information should be directed to Kaila Fayne at Kaila.Fayne@dca.ca.gov or (916) 465-9120.

1. Call to Order and Establishment of a Quorum
Matt Rahn, Chair, Cannabis Advisory Committee

2. Review and Approval of May 17, 2018 Cannabis Advisory Committee Meeting Minutes

3. Review and Approval of July 19, 2018 Cannabis Advisory Committee Meeting Minutes

4. Chair’s Report: Status of the Advisory Committee’s Adopted Recommendations in the Current and Proposed Regulations of the Bureau of Cannabis Control, California Department of Food and Agriculture, and California Department of Public Health

a. Adopted Recommendations on Cultivators
• Generator Hour Meters (Recommendation #1)
• Outdoor Cultivation Definition (Recommendation #2)
• Transfer Between A & M Licenses (Recommendation #6)
• Compassionate Use Programs (Recommendation #7)
• Self-Transport Distribution (Recommendation #11)

b. Adopted Recommendations on Distributors
• Selling Samples (Recommendation #1)
• Additional Label (Recommendation #2)
• Storage Only Center License (Recommendation #3)
• Transition Period Extension (Recommendation #4)

c. Adopted Recommendations on Enforcement
• Enforcement Authority (Recommendation #1)
• Clarify Difference Between Citations and Orders of Abatement and Clarify References
(Recommendation #2)
• Advertising (Recommendation #6)
• Public Records Act Requests (Recommendation #8)
• Labor Standards (Recommendation #9)

d. Adopted Recommendations on Equity
• State Level Equity Licensing Program (Recommendation #1)
• Earmarks, Fee Waivers, and Loans (Recommendation #2)
• Fee Installments and Deferrals (Recommendation #3)
• Research Support (Recommendation #4)
• Access to Property and Premises (Recommendation #5)
• Data Collection (Recommendation #6)
• Funding of a Social Equity Program (Recommendation #7)
• Local Program Models (Recommendation #8)

e. Adopted Recommendations on Licensing Application
• Disclosure of Owners (Recommendation #2)
• Annual Fees (Recommendation #4)
• A and M Licenses and Transition Period (Recommendation #5)
• Use of Preparers (Recommendation #6)

f. Adopted Recommendations on Manufacturers
• Illustrative Guide (Recommendation #1)
• Clarification on Packaging (Recommendation #2)
• Child-Resistant Packaging (Recommendation #3)
• Dosage Limits (Recommendation #4)

g. Adopted Recommendations on Microbusiness
• License Tiers, Incentives for Compassionate Use and Rural Operators, and Fee Schedule Cap
(Recommendation #2)

h. Adopted Recommendations on Public Health and Youth
• Proper Identification Training (Recommendation #1)
• Compassionate Medical Cannabis (Recommendation #2)
• Branded Vehicles (Recommendation #3)
• Health Claim Advertising (Recommendation #4)
• Data Collection (Recommendation #5)
• Advertising to Age Specific Audience (Recommendation #6)
• Compassionate Care Program (Recommendation #7)

i. Adopted Recommendations on Retailers
• Methods of Delivery (Recommendation #1)

j. Adopted Recommendations on Testing Laboratories
• Testing for Research and Development (Recommendation #1)
• Expiration Date (Recommendation #2)
• Standard Testing Analytical Methodology (Recommendation #3)
• Waste Disposal (Recommendation #4)

5. Discussion and Possible Action regarding Submission of the Advisory Committee’s Adopted Recommendations
as Public Comment on the Proposed Regulations of the Bureau of Cannabis Control, California Department of
Food and Agriculture, and California Department of Public Health

6. Discussion and Possible Action on Section 5416 (d) of the Bureau of Cannabis Control’s Proposed Regulations
Pertaining to Delivery

7. Discussion and Possible Action on Section 5500 of the Bureau of Cannabis Control’s Proposed Regulations
Pertaining to Microbusiness

8. Discussion and Possible Action on the Advisory Committee’s Annual Report

9. Public Comment on Items Not on the Agenda

The committee may not discuss or take action on any matter raised during the public comment section that is not included on this agenda, except whether to decide to place the matter on the agenda of a future meeting.
(Government Code §§ 11125 and 11125.7 (a).)

10. Future Agenda Items

11. Adjournment